AVAXIM
Hepatitis A virus, inactivated
160 U / 0.5 mL · suspension · intramuscular · 12 years and older
Hepatitis A
Hepatitis A
AVAXIM · HAVRIX 1440 · HAVRIX 720 JUNIOR · VAQTA
Two doses, 6 or more months apart. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
- Products
- 4
- Dose schedules
- 3
- Guidance checked
- 2026-09-27
Authorized products
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
HAVRIX 1440
Hepatitis A virus, inactivated
1440 U / 1 mL · suspension · intramuscular · 19 years and older
HAVRIX 720 JUNIOR
Hepatitis A virus, inactivated
720 U / 0.5 mL · suspension · intramuscular · 6 months to 18 years
VAQTA
Hepatitis A vaccine, inactivated
50 U / 1 mL · suspension · intramuscular · 18 years and older
Before and after vaccination
- Bring your immunization record so earlier doses can be checked.
- Discuss a serious reaction to a previous vaccine, relevant health conditions, medicines and allergies before receiving a dose.
- After vaccination, stay where you can be observed for at least 15 minutes and report feeling faint or signs of an allergic reaction right away.
- Keep the vaccine name, date and dose in your immunization record.
Based on the Canadian Immunization Guide's administration practices and acute reactions guidance.
Pregnancy & breastfeeding
Pregnancy
Use if indicated: after an exposure, or for travel to an endemic area.
Breastfeeding
Use if indicated.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
How many doses
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
Hepatitis A — adult and adolescent two-dose series
2 dosesTwo doses of hepatitis A vaccine, the second 6 to 36 months after the first depending on the product.
Adult products: HAVRIX 1440 for 19 years and older (dose 2 at 6 to 12 months), AVAXIM for 12 years and older (dose 2 at 6 to 36 months), VAQTA adult for 18 years and older (dose 2 at 6 to 18 months). One dose gives protective antibody in nearly all recipients; the second gives long-term protection.
ProductsHAVRIX 1440AVAXIMVAQTA
Hepatitis A — child two-dose series (6 months to 18 years)
2 dosesTwo doses of paediatric hepatitis A vaccine, the second 6 to 12 months after the first.
HAVRIX 720 Junior is authorized from 6 months to less than 19 years of age. Publicly funded eligibility varies by province. The series is complete after the second dose.
ProductsHAVRIX 720 JUNIOR
Hepatitis A — weakened immune system, two doses
2 dosesStandard two-dose hepatitis A series; the response may be reduced.
Hepatitis A vaccine may be given to immunocompromised people; the response may be reduced but the vaccine still offers some protection. Immune globulin may be considered for pre- and post-exposure protection, and blood testing after immunization may be considered where available.
ProductsHAVRIX 1440AVAXIMVAQTAHAVRIX 720 JUNIOR
References and product information
- Hepatitis A vaccines: Canadian Immunization Guide — Chapter revised March 2018
- Vaccine administration practices: Canadian Immunization Guide
- Anaphylaxis and other acute reactions: Canadian Immunization Guide
- Health Canada Drug Product Database — product records and monographs
- Pharmasist vaccine reference: HAVRIX 720 JUNIOR
- Pharmasist vaccine reference: VAQTA
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.